Circulatory Technology Inc

Form 483 issued July 8, 2016 · Oyster Bay, New York

Inspection
Jun 6 – Jul 8, 2016
Investigator
Ronald Ifraimov
Observations
10
Pages
7
FEI number
1000522036

In short: On July 8, 2016, FDA issued a Form 483 with 10 observations to Circulatory Technology Inc in Oyster Bay, New York (FEI 1000522036) after an inspection that ran Jun 6 – Jul 8, 2016. The investigator was Ronald Ifraimov. Most observations concern cAPA and design controls; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

CAPA and design controls account for 8 of 10 observations.

CAPA4
Design controls4
Production & process controls2

What FDA observed

Preview: the opening words of each observation
  1. 01

    An MDR report was not submitted within 30 days of receiving or otherwise becoming aware of…

  2. 02

    A submitted MDR event was not evaluated in accordance with the requirements of the regulations regarding…

  3. 03

    The design history file was not established and does not demonstrate that the design was developed…

  4. 04

    Design plans that describe or reference the design and development activities and define responsibility for implementation…

6 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Circulatory Technology Inc?

FDA listed 10 observations on this Form 483, mostly about cAPA, design controls and production & process controls. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Circulatory Technology Inc?

Ronald Ifraimov is named on this Form 483, for the inspection of Jun 6 – Jul 8, 2016. Each investigator has a profile showing what they cite most.

When was Circulatory Technology Inc inspected by FDA?

The inspection ran Jun 6 – Jul 8, 2016, and the Form 483 is dated July 8, 2016.

How do I get the full Form 483 for Circulatory Technology Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free